Martinsried/Munich, 17 December 2015. Medigene AG (MDG1, Frankfurt, Prime Standard), a clinical stage immunotherapy company focussing on the development of T-cell therapy platforms for the treatment ...

Martinsried/Munich, 1 October 2013. Medigene AG (MDG, Frankfurt, Prime Standard) announced today that its partner SynCore, a member of the Sinphar Pharmaceutical Group, has started the launch of ...

SynCore Biotechnology Co (杏國新藥) has begun the race to introduce SB05PC, its new pancreatic cancer drug, to the Chinese market as a first-line treatment. The company has begun enrolling patients in a ...

The unblinding of phase 3 trial data of SynCore Biotechnology Co Ltd’s (杏國新藥) newly developed pancreatic cancer drug SB05PC showed no statistical significance when compared with the control group, the ...

Sedo released their weekly domain name sales and Syncore.com led the way at 91,500 Euro, ($108,133). NovoCapital.com was second at $31,000 and Manager.ai was third at $30,000.

1 Day 4192 -3.20% DJIA 0.09% S&P Mid Cap 400 0.33% Health Care/Life Sciences -1.48% ...

SynCore BioTech (4192) has delivered a -29.99% change over the past year, with a 52-week range between 23.90 and 38.50. What Is the Average Daily Trading Volume of SynCore BioTech (4192)? The average ...

Determining whether SynCore Biotechnology Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Visit a quote page and your recently viewed tickers will be displayed here.

4726.TWO Mycenax Biotech Inc.